Panel supports wider use of Medicis' wrinkle filler Restylane

04/27/2011 | Reuters

Medicis Pharmaceutical gained support from an FDA advisory panel for wrinkle injection Restylane to enhance lips. Advisers said the gel-based product appears safe and effective for lip augmentation without causing serious adverse events.

View Full Article in:

Reuters